Why is Panacea Biotec falling/rising?

As of 25-Sep, Panacea Biotec Ltd's stock price is currently at 419.35, reflecting an increase of 12.6 or 3.1%. The stock has shown a trend reversal, gaining after five consecutive days of decline, and it outperformed its sector by 3.96% today. Over the past week, the stock has decreased by 5.57%, but it has increased by 4.45% over the past month and has generated a significant return of 45.91% over the last year. However, the company faces challenges, such as operating losses and a weak long-term fundamental strength, indicated by a poor EBIT to Interest ratio and negative EBITDA. Despite these concerns, the stock's consistent returns over the last three years may have contributed to its recent price increase.
In the broader market context, while Panacea Biotec's stock has outperformed the Sensex by 3.96% today, it has still experienced a decline of 5.57% over the past week compared to the Sensex's drop of 2.23%. The stock's performance over the last year is notably strong, with a return of 45.91%, contrasting with the Sensex's decline of 4.71%. However, the falling investor participation, as indicated by a significant drop in delivery volume, suggests that market sentiment may be cautious despite the recent price rise. This mixed performance highlights the stock's volatility and the potential risks associated with its underlying fundamentals.